Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer

NCT00002939 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: irinotecan hydrochloride
DRUG: paclitaxel

Sponsor

University of Chicago

Collaborators

[object Object]